Terms: = Germ cell tumor AND CEACAM5, CEA AND Staging
20 results:
1. Preoperative neck ultrasound combined with pathological data can significantly impact the outcome of medullary thyroid carcinoma.
Deandrea M; Piticchio T; Mormile A; Retta F; Canale G; Caracciolo A; Daniele L; Trimboli P
Endocr J; 2023 Nov; 70(11):1061-1067. PubMed ID: 37690841
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of F-18 DOPA PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: comparison with GA-68 DOTA-TATE PET/CT.
Asa S; Sonmezoglu K; Uslu-Besli L; Sahin OE; Karayel E; Pehlivanoglu H; Sager S; Kabasakal L; Ocak M; Sayman HB
Ann Nucl Med; 2021 Aug; 35(8):900-915. PubMed ID: 33993425
[TBL] [Abstract] [Full Text] [Related]
3. Diagnostic value of [
Jamsek J; Hocevar M; Bergant D; Zaletel K; Rep S; Lezaic L
Ann Nucl Med; 2021 Apr; 35(4):429-437. PubMed ID: 33544320
[TBL] [Abstract] [Full Text] [Related]
4. An Overview of Medullary Thyroid Cancer Cases Treated at Kuwait Cancer Control Center.
Shete J; AlSaleh K; Safwat R; Bedair A; ElSherify M; Hussein A; Nazeeh M; Mohanty A
Gulf J Oncolog; 2020 Sep; 1(34):39-47. PubMed ID: 33431361
[TBL] [Abstract] [Full Text] [Related]
5. Role of tissue and circulating microRNAs and DNA as biomarkers in medullary thyroid cancer.
Chiacchiarini M; Trocchianesi S; Besharat ZM; Po A; Ferretti E
Pharmacol Ther; 2021 Mar; 219():107708. PubMed ID: 33091426
[TBL] [Abstract] [Full Text] [Related]
6. Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer.
Turkdogan S; Forest VI; Hier MP; Tamilia M; Florea A; Payne RJ
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):55. PubMed ID: 30223887
[TBL] [Abstract] [Full Text] [Related]
7. High cea levels in a case of resected colorectal cancer: delayed diagnosis of metachronous medullary thyroid cancer.
Chen SW; Chen YK
World J Surg Oncol; 2017 Dec; 15(1):230. PubMed ID: 29284496
[TBL] [Abstract] [Full Text] [Related]
8. Charting a course through the ceas: diagnosis and management of medullary thyroid cancer.
Rowe CW; Bendinelli C; McGrath S
Clin Endocrinol (Oxf); 2016 Sep; 85(3):340-3. PubMed ID: 27230389
[TBL] [Abstract] [Full Text] [Related]
9. Long-Term Follow-up in Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
[TBL] [Abstract] [Full Text] [Related]
10. [Histological and immunohistochemical profile of sporadic and familial medullary thyroid carcinoma].
Ríos A; Rodríguez JM; Febrero B; Acosta Ortega JM; Torregrosa N; Balsalobre M; Parrilla P
Endocrinol Nutr; 2011 Dec; 58(10):521-8. PubMed ID: 22047736
[TBL] [Abstract] [Full Text] [Related]
11. Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapy.
Oudoux A; Salaun PY; Bournaud C; Campion L; Ansquer C; Rousseau C; Bardet S; Borson-Chazot F; Vuillez JP; Murat A; Mirallié E; Barbet J; Goldenberg DM; Chatal JF; Kraeber-Bodéré F
J Clin Endocrinol Metab; 2007 Dec; 92(12):4590-7. PubMed ID: 17878252
[TBL] [Abstract] [Full Text] [Related]
12. [PET in thyroid cancers].
Talbot JN; Montravers F; Younsi N; Zanotti-Fregonara P; Grahek D; Kerrou K; Gutman F; Périé S; Maurel G; Saint Guily JL; Devaux JY; Duron F
Presse Med; 2006 Sep; 35(9 Pt 2):1377-85. PubMed ID: 16969334
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.
Barbet J; Campion L; Kraeber-Bodéré F; Chatal JF;
J Clin Endocrinol Metab; 2005 Nov; 90(11):6077-84. PubMed ID: 16091497
[TBL] [Abstract] [Full Text] [Related]
14. [AFP-producing adenocarcinoma of the stomach. A rare tumor with poor prognosis].
Kaiser U; Zugmaier G; Frank M; Riedel I; Neubauer A; Moll R
Pathologe; 2003 Mar; 24(2):141-5. PubMed ID: 12673505
[TBL] [Abstract] [Full Text] [Related]
15. [Usefulness of serum calcitonin, cea and AFP assays in the early detection of medullary thyroid carcinoma relapse].
Łacka K; Michałek K; Majewski P
Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
[TBL] [Abstract] [Full Text] [Related]
16. Intraoperative use of gamma-detecting probes to localize neuroendocrine tumors.
Adams S; Baum RP
Q J Nucl Med; 2000 Mar; 44(1):59-67. PubMed ID: 10932602
[TBL] [Abstract] [Full Text] [Related]
17. Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors?
Behr TM; Gratz S; Markus PM; Dunn RM; Hüfner M; Schauer A; Fischer M; Munz DL; Becker H; Becker W
Cancer; 1997 Dec; 80(12 Suppl):2436-57. PubMed ID: 9406695
[TBL] [Abstract] [Full Text] [Related]
18. Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen.
Juweid M; Sharkey RM; Behr T; Swayne LC; Rubin AD; Herskovic T; Hanley D; Markowitz A; Dunn R; Siegel J; Kamal T; Goldenberg DM
J Clin Oncol; 1996 Apr; 14(4):1209-17. PubMed ID: 8648376
[TBL] [Abstract] [Full Text] [Related]
19. Clinical usefulness of serum ferritin measurements in patients with testicular germ cell tumors.
Szymendera JJ; Kozłowicz-Gudzinska I; Madej G; Sikorowa L; Kaminska JA; Kowalska M
Oncology; 1985; 42(4):253-8. PubMed ID: 2409496
[TBL] [Abstract] [Full Text] [Related]
20. Value of five tumor markers (AFP, cea, hCG, hPL and SP1) in diagnosis and staging of testicular germ cell tumors.
Szymendera JJ; Zborzil J; Sikorowa L; Kamińska JA; Gadek A
Oncology; 1981; 38(4):222-9. PubMed ID: 6165945
[TBL] [Abstract] [Full Text] [Related]